The Promise of Regenerative Medicine in the Reconstruction of Auricular Cartilage Deformities.
Mehrdad SeifiSadrollah MotamedAbdolreza RouientanMahboubeh BohlouliPublished in: ASAIO journal (American Society for Artificial Internal Organs : 1992) (2023)
There are many physiologic and psychologic challenges associated with ear cartilage deformities which are incredibly distasteful to patients, particularly children. The development of regenerative medicine (RM) sciences has opened up a new window for the reconstruction of auricular cartilage because it allows the creation of a structure similar to the auricular in appearance and function. As part of this review, we discuss the role that each RM tool, including tissue engineering, cells, and biomolecules, plays in developing engineered auricular tissue. In previous studies, it was shown that the simultaneous use of natural and synthetic biomaterials as well as three-dimensional printing techniques could improve the biological and mechanical properties of this tissue. Another critical issue is using stem cells and differentiated cartilage cells to produce tissue-specific cellular structures and extracellular matrix. Also, the importance of choosing a suitable animal model in terms of handling and care facilities, physiologic similarities to humans, and breed uniformity in the preclinical assessments have been highlighted. Then, the clinical trials registered on the clinicaltrials.gov website, and the commercialized product, called AuriNovo, have been comprehensively explained. Overall, it is important to provide engineered auricular cartilage structures with acceptable safety and efficacy compared with standard methods, autologous cartilage transplantation, and prosthetic reconstruction in RM.
Keyphrases
- extracellular matrix
- stem cells
- tissue engineering
- induced apoptosis
- clinical trial
- cell therapy
- end stage renal disease
- cell cycle arrest
- healthcare
- ejection fraction
- chronic kidney disease
- young adults
- palliative care
- oxidative stress
- newly diagnosed
- high resolution
- endoplasmic reticulum stress
- randomized controlled trial
- prognostic factors
- bone marrow
- mesenchymal stem cells
- mass spectrometry
- cell death
- chronic pain
- case control
- open label
- phase ii
- artificial intelligence